News

electroCore to Present at the Canaccord Genuity Growth Conference

Health
0 min read


electroCore to Present at the Canaccord Genuity Growth Conference

 

ROCKAWAY, NJ
Aug. 02, 2021 (GLOBE NEWSWIRE) — 
electroCore, Inc. (the “Company”), (NASDAQ: ECOR), a commercial-stage bioelectronic medicine company, today announced that its management team will give a corporate presentation and be available for virtual one-on-one meetings at the 
Canaccord Genuity Growth Conference. The conference is taking place virtually from 
August 10 – 12, 2021. Details for the presentation are as follows:

Canaccord Genuity Growth Conference:
Date: 
Thursday, August 12, 2021
Time: 
8:30 am EDT
Investors can register for the conference HERE.

Following the conference a webcast replay of the presentation will be available on the Investor section of the company’s website, www.electrocore.com.

About electroCore, Inc.
electroCore, Inc. is a commercial stage bioelectronic medicine company dedicated to improving patient outcomes through its non-invasive vagus nerve stimulation therapy platform, initially focused on the treatment of multiple conditions in neurology. The company’s current indications are the preventive treatment of cluster headache and migraine and the acute treatment of migraine and episodic cluster headache.

For more information, visit www.electrocore.com.


Investors:
Rich CockrellCG Capital
404-736-3838
[email protected]

or

Media Contact:
Jackie Dorsky
electroCore
908-313-6331
[email protected]
Share

Inbox Intel from Channelchek.

Informed investors make more money. And it’s all about timing. Get it when it happens.

By clicking submit you are agreeing to the Terms of Use and Privacy Policy
© 2018-2024 Noble Financial Group, Inc. All Rights Reserved. Channelchek is provided at no cost to be used for information purposes only and not as investment advisement.